Federal Register / Vol. 89, No. 247 / Thursday, December 26, 2024 / Notices 105059 

records about subscribers, which are 

retrieved by the subscriber’s name or 

email address. 

POLICIES AND PRACTICES FOR RETENTION AND

DISPOSAL OF RECORDS: 

Records about individuals who serve 

as members of Federal advisory 

committees and subgroups are retained 

and disposed of in accordance with 

NARA General Records Schedule (GRS) 

6.2, Items 010, 040, and 050: 

• Item 010 Substantive Committee 

Records requires substantive records 

related to committee and subgroup 

membership to be accessioned to the 

National Archives for permanent 

retention when the records are 15 years 

old or older or upon termination of the 

committee, whichever is sooner. 

• Item 040 Committee Accountability 

Records (note that this item excludes 

forms filed under the Ethics in 

Government Act, and such forms are not 

covered by this SORN) authorizes 

accountability records (such as records 

about members’ financial disclosures 

and conflicts of interest, and records 

documenting travel and other payments 

to or for committee members) to be 

destroyed when 6 years old unless 

longer retention is required for business 

use. 

• Item 050 Non-substantive 

Committee Records authorizes records 

of an administrative nature, such as 

those documenting members’ and 

prospective members’ credentials, to be 

destroyed when superseded, obsolete, or 

no longer needed, or upon termination 

of the committee, whichever is sooner. 

Records about prospective members 

of Federal advisory committees are 

retained and disposed of in accordance 

with GRS 6.2, Item 050 (see above). 

Records about guest speakers are 

disposed of in accordance with GRS 6.2, 

Item 040 (see above). 

Records about meeting registrants and 

subscribers are retained and disposed of 

in accordance with GRS 6.5, Item 020, 

which authorizes sign-up forms and 

distribution lists for distributing 

information such as publications and 

data produced by the agency to be 

deleted when superseded or obsolete or 

when the customer requests the agency 

to remove the records. 

ADMINISTRATIVE, TECHNICAL, AND PHYSICAL

SAFEGUARDS: 

Records are protected from 

unauthorized access through 

appropriate administrative, physical, 

and technical safeguards. Safeguards 

conform to the HHS Information 

Security and Privacy Program, https://

www.hhs.gov/ocio/securityprivacy/. The 

safeguards include protecting the 

facilities where records are stored or 

accessed with security guards, badges, 

and cameras; securing hard-copy 

records in locked file cabinets, file 

rooms or offices during off-duty hours; 

limiting access to electronic databases to 

authorized users based on roles, the 

principle of least privilege, and either 

two-factor authentication or user ID and 

password; using a secured operating 

system protected by encryption, 

firewalls, and intrusion detection 

systems; encrypting data transmissions 

and records stored on removable media; 

using secure destruction methods 

prescribed in National Institute of 

Standards and Technology Special 

Publication 800–88 to dispose of eligible 

records; and training personnel in 

Privacy Act and information security 

requirements. 

RECORD ACCESS PROCEDURES: 

An individual seeking access to 

records about him or her in this system 

of records must submit a written access 

request to the relevant System Manager, 

at the address indicated in the ‘‘System 

Manager(s)’’ section, above, in 

accordance with the Department’s 

Privacy Act implementation regulations 

in 45 CFR. The request must contain the 

individual’s full name and address, and, 

for identity verification purposes, 

signature, and date and place of birth. 

In addition, to verify the individual’s 

identity, the individual must provide 

either a notarized request or a written 

certification that the individual is who 

he or she claims to be and understands 

that the knowing and willful request for 

acquisition of a record pertaining to an 

individual under false pretenses is a 

criminal offense under the Privacy Act, 

subject to a fine of up to $5,000. 

CONTESTING RECORD PROCEDURES: 

An individual seeking to amend a 

record about him or her in this system 

of records must submit a written 

amendment request to the relevant 

System Manager, at the address 

indicated in the ‘‘System Manager(s)’’ 

section, above, in accordance with the 

Department’s Privacy Act 

implementation regulations in 45 CFR. 

The request must contain the same 

information required for an access 

request, and must reasonably identify 

the record, specify the information 

contested, state the corrective action 

sought, provide the reasons for the 

amendment, and include any 

supporting justification or 

documentation. The individual must 

verify his or her identity in the same 

manner required for an access request. 

The right to contest records is limited to 

information that is factually inaccurate, 

incomplete, irrelevant, or untimely 

(obsolete). 

NOTIFICATION PROCEDURES: 

An individual who wishes to know if 

this system of records contains records 

about him or her must submit a written 

notification request to the relevant 

System Manager at the address 

indicated in the ‘‘System Manager(s)’’ 

section, above, in accordance with the 

Department’s Privacy Act 

implementation regulations in 45 CFR. 

The request must contain the same 

information required for an access 

request, and the individual must verify 

his or her identity in the same manner 

required for an access request. 

EXEMPTIONS PROMULGATED FOR THE SYSTEM: 

None. 

HISTORY: 

47 FR 45514 (October 13, 1982); 59 FR 

55845 (November 9, 1994); 83 FR 6591 

(February 14, 2018). 

Dated: December 13, 2024. 

P. Ritu Nalubola, 

Associate Commissioner for Policy. 

[FR Doc. 2024–30782 Filed 12–23–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–N–4776] 

Export Lists for Human Food: Request 

for Information; Extension of Comment 

Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; request for information; 

extension of comment period. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

extending the comment period for the 

request for information, published in 

the Federal Register of November 8, 

2024. In that notice, FDA invited 

comment relating to the listing 

requirements of other countries and 

FDA’s approach to facilitating U.S. 

industry compliance with these 

requirements through the issuance of 

export certification for human food 

products provided in the form of lists 

(export lists). We are extending the 

comment period to allow interested 

persons additional time to submit 

comments on FDA’s approach. 

DATES: FDA is extending the comment 

period announced in the notice for 

request for information published 

November 8, 2024 (89 FR 88785). 


ddrumheller on DSK120RN23PROD with NOTICES1
105060 Federal Register / Vol. 89, No. 247 / Thursday, December 26, 2024 / Notices 

Electronic or written comments must be 

submitted by February 21, 2025. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. The https://

www.regulations.gov electronic filing 

system will accept comments until 

11:59 p.m. Eastern Time at the end of 

February 21, 2025. Comments received 

by mail/hand delivery/courier (for 

written/paper submissions) will be 

considered timely if they are received 

on or before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2024–N–4776 for ‘‘Export Lists for 

Human Food: Request for Information.’’ 

Received comments, those filed in a 

timely manner (see ADDRESSES), will be 

placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ We 

will review this copy, including the 

claimed confidential information, in our 

consideration of comments. The second 

copy, which will have the claimed 

confidential information redacted/ 

blacked out, will be available for public 

viewing and posted on https://

www.regulations.gov. Submit both 

copies to the Dockets Management Staff. 

If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

FOR FURTHER INFORMATION CONTACT: 

Lauren Ferguson Baham, Office of 

Policy, Regulations, and Information, 

Human Foods Program, Food and Drug 

Administration, 5001 Campus Dr., 

College Park, MD 20740, 240–402–2371. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of November 8, 2024, 

we published a notice announcing a 

request for information. The notice 

explained our export certification for 

human foods and that FDA is 

considering charging firms fees for our 

export list services to offset our costs. 

The notice also explained that, as of 

August 2024, we provide certification in 

the form of export lists that cover 19 

categories of products for six 

destinations: Chile, China, the European 

Union, Saudi Arabia, Taiwan, and the 

United Kingdom. Further, the notice 

explained that, to better inform the 

continuing development of our export 

list program for human foods, we 

invited public comment on the 

following: 

• There are many different types of 

establishment listing and certification 

procedures for establishments that 

produce human food products. Please 

share your experience with other 

countries’ establishment listing, 

certification, and registration 

requirements. 

• FDA requires those on export lists 

to reapply regularly if they wish to 

remain listed. Do reapplicants 

experience any challenges with the 

renewal process? If you have 

experienced challenges, how were those 

challenges resolved? 

• For those included on export lists, 

please describe any challenges you have 

experienced with exporting human food 

products included on the export lists. 

• FDA is authorized to collect up to 

$175 per certification for each company 

and its human food products that FDA 

certifies through inclusion on an export 

list. For those that would be charged a 

fee, do you have any specific 

suggestions about how FDA should 

approach the implementation of fees? 

Please provide details relating to any 

suggestions you might have (89 FR 

88785). 

The docket for public comments was 

scheduled to close January 7, 2025. 

We have received several requests to 

extend the comment period. In general, 

the requests explain that FDA’s 

consideration to charge fees for its 

export list services to offset costs is a 

significant change from current Agency 

practice that will take firms time to fully 

evaluate the impacts of the proposed 

changes and to provide substantive 

comment that details firms’ experiences 

and challenges with export lists. The 

requests also note that the comment 

period overlaps with the holiday season. 

We have considered the requests and 

are extending the comment period until 

February 21, 2025. We believe that the 

extension will allow adequate time for 

interested persons to submit comments. 

Dated: December 18, 2024. 

P. Ritu Nalubola, 

Associate Commissioner for Policy. 

[FR Doc. 2024–30784 Filed 12–23–24; 8:45 am] 

BILLING CODE 4164–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1